greeksoup/ stocks
Stocks / Foreign companies / NVS · Pharmaceutical Preparations

Novartis AG (NVS)

Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2025 it reported revenue from the sale of goods of USD 54,532 million, up 8.4% on the year before. Its profit attributable to shareholders was USD 13,984 million, up 17.1%, and diluted earnings per share USD 7.15.

Earnings per share are per ordinary share, in US dollars. The share that trades in the US can be a depositary share standing for more or fewer ordinary shares, so no price ratio is worked out on this page.

The public record on NVS

Planned insider sales3 Form 144 notices in twelve months, $7.1 million; latest 30 April 2026
Options tapeput/call 1.59 by open interest on 26 September 2026; the straddle prices a 4.0% move to 16 October 2026
Holders7 of the followed funds hold it; largest FMR LLC; 0 Schedule 13D or 13G filings in twelve months
Congress0 House trades disclosed in six months
Short interest5.2 million shares short, 1.47 days to cover at 15 September 2026

Profit and loss, 10 fiscal years

Year toDec 2025Dec 2024Dec 2023Dec 2022*Dec 2021*Dec 2020*Dec 2019Dec 2018*Dec 2017*Dec 2016
Revenue from the sale of goods54,53250,31745,44042,20642,78148,65947,49844,83342,38148,518
Cost of sales13,69912,82712,47211,58211,73515,12114,42514,51013,63317,520
Gross profit42,97538,89534,18831,87932,23934,77734,25231,58929,77131,916
Research and development11,20010,02211,3719,1728,6418,9809,4028,4898,3899,039
Selling, general and administrative13,24812,56612,51712,19312,82714,19714,36913,71712,46514,192
Operating profit17,64414,5449,7697,94610,05610,1529,0868,4038,7028,268
Profit before tax16,35213,6409,1237,17724,5309,8788,94014,0959,1027,817
Income tax2,3851,7015511,1281,6251,8071,7931,2951,6031,119
Profit for the year13,96711,93914,8546,95524,0188,07111,73712,6147,7036,698
Profit attributable to shareholders13,98411,94114,8506,95524,0218,07211,73212,6117,7036,712

USD million, from each year's annual report on the SEC's EDGAR, the year linked to its filing, on the IFRS tags the company filed. A line the company does not file under the standard tag is left out rather than estimated. A year marked * shows the figure as the company restated it in a later annual report (Dec 2017, Dec 2018, Dec 2020, Dec 2021, Dec 2022); the first-filed figure is in the CSV. Profit for the year includes the part that belongs to minority shareholders; profit attributable to shareholders is the part EPS is struck on.

Year toDec 2025Dec 2024Dec 2023Dec 2022*Dec 2021*Dec 2020*Dec 2019Dec 2018*Dec 2017*Dec 2016
Diluted EPS7.155.877.103.1710.633.525.065.383.252.80
Basic EPS7.215.927.153.1910.713.555.125.443.282.82

USD per ordinary share, as filed.

Cash flow

Year toDec 2025Dec 2024Dec 2023Dec 2022*Dec 2021*Dec 2020*Dec 2019Dec 2018*Dec 2017*Dec 2016
Cash from operations19,14417,61914,45814,23615,07113,65013,62514,27212,62111,475
Purchase of property, plant and equipment1,5481,3661,0609161,0661,2751,3791,2541,3251,862
Free cash flow17,59616,25313,39813,32014,00512,37512,24613,01811,2969,613
Dividends paid7,8187,6247,2557,5067,3686,9876,6456,9666,4956,475

USD million. Purchase of property, plant and equipment is the cash line as filed; purchases of intangible assets and acquisitions are not in it. Free cash flow is cash from operations less that purchase, arithmetic on the two filed lines.

Balance sheet at year end

Year toDec 2025Dec 2024Dec 2023Dec 2022*Dec 2021*Dec 2020*Dec 2019Dec 2018*Dec 2017*Dec 2016
Total assets110,949102,24699,945117,453131,795127,778118,370145,563133,079n/a
Equity attributable to shareholders46,13044,04646,66759,34267,65556,59855,47478,61474,16874,891
Cash and cash equivalents11,43511,45913,3937,51712,4079,65811,11213,2718,8607,007
Borrowings, as filed28,72924,72220,62722,48525,52328,53122,35525,66023,583n/a
Lease liabilities1,9201,8031,8281,7891,8962,0051,949n/an/an/a
Inventories6,2695,7235,9137,1756,6667,1315,9826,9566,867n/a
Goodwill25,56724,75623,34129,30129,59529,99926,52435,29431,750n/a

USD million, at each fiscal year end. Borrowings is the company's own stated total where it files one; it is never added up from its parts here.

Ratios on the filed lines

Year toDec 2025Dec 2024Dec 2023Dec 2022*Dec 2021*Dec 2020*Dec 2019Dec 2018*Dec 2017*Dec 2016
Return on year-end equity30.3%27.1%31.8%11.7%35.5%14.3%21.1%16.0%10.4%9.0%
Effective tax rate14.6%12.5%6.0%15.7%6.6%18.3%20.1%9.2%17.6%14.3%

Arithmetic on the filed lines of the same year: margins over revenue, return on equity as profit attributable to shareholders over year-end equity, tax over profit before tax.

Annual reports on EDGAR

FormYear toFiled
20-F31 December 20254 February 2026EDGAR
20-F31 December 202431 January 2025EDGAR
20-F31 December 202331 January 2024EDGAR
20-F/A31 December 202215 May 2023EDGAR
20-F31 December 20221 February 2023EDGAR
20-F/A31 December 202126 April 2022EDGAR
20-F31 December 20212 February 2022EDGAR
20-F31 December 202026 January 2021EDGAR
20-F31 December 201929 January 2020EDGAR
20-F31 December 201830 January 2019EDGAR
20-F31 December 201724 January 2018EDGAR
20-F31 December 201625 January 2017EDGAR

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install